Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 4.05% 1.925 1.85 2.00 1.95 1.85 1.85 16,995,957 16:06:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.1 -0.0 - 63

Sareum Share Discussion Threads

Showing 12151 to 12175 of 12500 messages
Chat Pages: Latest  488  487  486  485  484  483  482  481  480  479  478  477  Older
DateSubjectAuthorDiscuss
21/12/2020
21:17
Zak mir doesnt know from its assshole to esrhole. 25p in 2021 by july
spacedust
21/12/2020
20:50
Around a 3.7p short term target from Zar Mir chartist tonight over next six to eight weeks. Fingers crossed dyor
jpuff
21/12/2020
15:22
in simpler language: Ifnar2 and tyk2 Dec 17 The study, published in the journal Nature, analyzed the DNA from 2,700 of the participants who were in the ICU and found differences in 5 of their genes when compared to those of the healthy samples. The genes, IFNAR2, TYK2, OAS1, DPP9 and CCR2, can potentially begin to explain why some patients with COVID-19 become severely sick, while others are less effected by the virus. Genes were implicated in two important molecular processes, antiviral immunity and lung inflammation, which the investigators used to predict the effect of certain therapies. For example, it was shown that a reduction in the activity of the TYK2 gene can protect against Covid-19. JAK inhibitors, a class of anti-inflammatory drugs, are able to produce this effect. "This is a stunning realization of the promise of human genetics to help understand critical illness,” Kenneth Baillie, the study’s chief investigator said. “Just like in sepsis and influenza, in Covid-19, damage to the lungs is caused by our own immune system, rather than the virus itself." Findings also demonstrated that boosting the activity of the gene INFAR2 may help to create protection from COVID-19, due to the fact it is likely to mimic the effect of treatment with proteins released by cells of the immune system to defend against viruses. The team, based on these results, recommend that clinical trials should focus on targeting the pathways with drugs that are known to impact them. "Our results immediately highlight which drugs should be at the top of the list for clinical testing. We can only test a few drugs at a time, so making the right choices will save thousands of lives,” Baillie said. Https://www.contagionlive.com/view/genes-may-be-key-to-new-covid-19-treatments
andrbea
21/12/2020
15:18
Yup if this finishes anything above 2.5p then next stop 9p.....
spacedust
21/12/2020
15:17
rocket fuel again ..
andrbea
21/12/2020
15:15
Now its that its goodbye to 2p the share price now must be 3p. There are no other otpions or choice. 3p is imminent
spacedust
21/12/2020
15:11
Biggest regret ciming to bobby
spacedust
21/12/2020
15:10
Took some profit earlier & whacked the funds into ALGW.
bobby.ifa
21/12/2020
12:05
100m volume day?
spacedust
21/12/2020
11:41
Just a nob!
barkboo
21/12/2020
11:28
is justrying a shorter?
red5
21/12/2020
10:19
We don’t seem to see much of justrying1. Perhaps he has given up trying here? You can only win nob of the week so many times.
barkboo
21/12/2020
10:17
true spacedust.
red5
21/12/2020
10:16
manage to get some more just in time on the opening
red5
21/12/2020
10:16
The new strain of c19 may have something to do with thr rise too
spacedust
21/12/2020
09:37
Peeps getting burned on the rise now the dip. Stock markets down too.
georgeo1
21/12/2020
09:03
Their lab trial which is grant funded by UK government will move into humans faster than first thought. Class is safe, baricitinib, we have second gen so safer. Worth at least 10p
monstersound
21/12/2020
09:02
Glaxo are in imho 👌
strongbuy
21/12/2020
09:01
And this: https://www.google.com/amp/s/amp.ft.com/content/424ad1e2-9984-4e10-9ffa-0ed08f4e598b Rolling review of data for drugs to treat unmet needs. SDC1801 treats COVID. This will move quick.
monstersound
21/12/2020
09:00
It has to be more than a punt?
barkboo
21/12/2020
08:57
Thanks hh. Speculation that Glaxo might take a chunk?
pennstreet
21/12/2020
08:51
this - hxxps://www.msn.com/en-gb/money/companies/pharma-giant-glaxosmithkline-set-to-cap-a-100m-spending-spree-with-two-major-drug-deals-either-side-of-atlantic/ar-BB1c4A5R?li=AAwnS0s
horridhenry
21/12/2020
08:46
What's fueling this rise?
pennstreet
21/12/2020
08:36
nice rise today
red5
18/12/2020
18:11
Ok thanks all
red5
Chat Pages: Latest  488  487  486  485  484  483  482  481  480  479  478  477  Older
ADVFN Advertorial
Your Recent History
LSE
SAR
Sareum
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210411 10:50:26